In contrast, most IDH-O and a large fraction of IDH-wt gliomas maintained telomere lengths via activation of telomerase (TEL) after promoter mutations of the TERT gene, which kept telomere lengths short but slightly above the telomere crisis threshold. The gene discussed is IDH1; the disease is central nervous system cancer.